Abstract. Background/Aim: The furo [2,3-b] chromone derivatives are natural products that have been used as folklore medicines for various diseases. Here, the cytotoxicity of 12 synthesized furo [2,3-b] 50 [2,3-b] [2,3-b] Many furochromone derivatives have been isolated from Ammi visnaga (Umbelliferae), used in folk medicine for different ailments. However, there are very few documentations of their synthetic methodologies and biological activities (1) . Sesquiterpene chromones isolated from Ferula fukanensis inhibited nitirc oxide (NO) production in lipopolysaccharide and interferon-γ-stimulated Raw264.7 mouse macrophage-like cells, through inhibition of inducible NO synthase gene expression (2) . Sesquiterpenoids isolated from the roots of Ferula mongolica were identified as new class of α-glucosidase inhibitors (3). Four oxepinochromenones (conioxepinols A-D) and one furochromenone (coniofurol A), from an organic solvent extract of solid-substrate fermentation culture of fungus Coniochaeta sp. (Coniochaetaceae) (4), and three sesquiterpene coumarin derivatives and two sesquiterpene chromone derivatives (5) showed moderate cytotoxicity against several human tumor cell lines. However, these previous studies did not investigate cytotoxicity against normal control cells.
chromone derivatives was investigated and subjected to quantitative structure-activity relationship (QSAR) analysis. Materials and Methods: Cytotoxicity against three human oral squamous cell carcinoma cell lines and three types of oral normal mesenchymal cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. Tumor specificity (TS) was evaluated as the ratio of the mean 50% cytotoxic concentration (CC

chromone derivatives showed relatively strong tumor selectivity. In particular, the derivatives with phenylethenyl and methoxy groups showed the highest TS, equivalent to that of melphalan, although their PSE values did not reach those of doxorubicin and 5-fluorouracil. Microscopical observation demonstrated that at cytotoxic concentrations, (2R,3aR,9aR)-rac-3a,9a-dihydro-7-methoxy-4-oxo-2-(2-phenylethenyl)-4H-furo[2,3-b][1]benzopyran-3,3(2H)-dicarboxylic acid 3,3-dimethyl ester and (2R,3aR,9aR)-rac-3a,9a-dihydro-7-methoxy-4-oxo-2-(1-propen-1-yl)-4H-furo[2,3-b][1]benzopyran-3,3(2H)-dicarboxylic acid 3,3-dimethyl ester did not produce a population of shrunken cells typical of apoptotic cells, in contrast to cells treated with actinomycin D. Tumor selectivity of furo
We established a simple in vitro assay system for assessing antitumor potential using human oral squamous cell carcinoma (OSCC) cell lines and human normal oral cells (6, 7) . Using this system, we have demonstrated that many anticancer drugs showed excellent tumor specificity (8) . Among a total of 133 compounds, (E)-3-[2-(4-hydroxyphenyl)ethenyl]-6-methoxy-4H-1-benzopyran-4-one (classified as 3-styrylchromone) (9, 10) , (E)-3-[2-(4-chlorophenyl)ethenyl]-7-methoxy-2H-1-benzopyran (classified as 3-styryl-2H-chromenes) (11) showed the highest tumor specificity with the least keratinocyte toxicity (7) .
In continuation of the discovery of new antitumor compounds, here 12 furo[2,3-b]chromones ( Figure 1 ) (12) were investigated for their cytotoxicity against three OSCC cell lines and three types of human normal oral cells, and then subjected to quantitative structure-activity relationship (QSAR) analysis.
Materials and Methods
Materials.
The following chemicals and reagents were obtained from the indicated companies: Dulbecco's modified Eagle's medium (DMEM), from GIBCO BRL, Grand Island, NY, USA; fetal bovine serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), doxorubicin from Sigma-Aldrich Inc., St. Louis, MO, USA; dimethyl sulfoxide (DMSO), culture plastic dishes and plates (96-well) were purchased from Becton Dickinson, Franklin Lakes, NJ, USA.
Synthesis of test compounds.
were synthesized by the ring-expansion reactions of methanochromanones with selected aldehydes or ketones, according to previous methods (12) . All compounds were dissolved in DMSO at 40 mM and stored at -20˚C before use.
Cell culture. Human normal oral mesenchymal cells (human gingival fibroblast, HGF; human periodontal ligament fibroblast, HPLF; human pulp cells, HPC) were established from the first premolar tooth extracted from the lower jaw of a 12-year-old girl (13) , and cells at 10-18 population-doubling levels were used in this study. Human OSCC cell lines [Ca9-22 (derived from gingival tissue); HSC-2, HSC-4 (derived from tongue)] were purchased from Riken Cell Bank (Tsukuba, Japan). All of these cells were cultured at 37˚C in DMEM supplemented with 10% heat-inactivated FBS, 100 units/ml, penicillin G and 100 μg/ml streptomycin sulfate under a humidified 5% CO 2 atmosphere. Cell morphology was checked periodically under the light microscope (EVOSfl; ThermoFisher Scientific, Waltham, MA, USA).
Assay for cytotoxic activity. Cells were inoculated at 2.5×10 3 cells/0.1 ml in a 96-microwell plate. After 48 h, the medium was replaced with 0.1 ml of fresh medium containing different concentrations of single test compounds. Cells were incubated further for 48 h and the relative viable cell number was then determined by the MTT method (8) (9) (10) (11) . The relative viable cell number was determined by the absorbance of the cell lysate at 560 nm using a microplate reader (Infinite F50R; TECAN, Kawasaki, Japan). Control cells were treated with the same amounts of DMSO and the cell damage induced by DMSO was subtracted from that induced by test agents. The concentration of compound that reduced the viable cell number by 50% (CC 50 ) was determined from the dose-response curve and the mean value of CC 50 for each cell type was calculated from triplicate assays.
Calculation of tumor-selectivity index (TS)
. TS was calculated using the following equation: TS=mean CC 50 against three types of normal oral cells/mean CC 50 against for OSCC cell lines [(D/B) in Table I ]. Since both Ca9-22 and HGF cells were derived from the gingival tissue (14) , the relative sensitivity of these cells was also compared [(C/A) in Table I ]. We did not use human normal oral keratinocytes as controls, since many anticancer drugs showed potent cytotoxicity against normal keratinocytes by inducing apoptosis (8) .
Calculation of potency-selectivity expression (PSE)
. PSE was calculated by the following equation: PSE=TS/CC 50 against tumor cells ×100 [that is, (D/B 2 ) ×100 (HGF, HPLF, HSC vs. Ca9-22, HSC-3, HSC-4) using all non-malignant and malignant cells, and (C/A 2 ) ×100 (HGF vs. Ca9-22) using the pair of the cells from the same tissue (gingiva) ( Table I) .
Estimation of CC 50 values.
Since the CC 50 values had a distribution pattern close to a logarithmic normal distribution, we used the pCC 50 (i.e., the −log CC 50 ) for the comparison of the cytotoxicity between the compounds. The mean pCC 50 values for normal cells and tumor cell lines were defined as N and T, respectively (11) . Seven MOE descriptors listed in Table II were significantly correlated with T, N and T-N. Since the use of Dragon descriptors produced heavy overlapping of similar descriptors that showed higher correlation with T, N and T−N, and therefore correlation diagrams were plotted using MOE descriptors.
Statistical treatment. The relationships among cytotoxicity. TS and chemical descriptors was investigated using simple regression analyses by JMP Pro version 12.2.0 (SAS Institute Inc., Cary, NC, USA). The significance level was set at p<0.05.
Results
Cytotoxicity. A total of 12 furo[2,3-b]chromones were synthesized, without (a series) or with (b series) introduction of methoxy group at C-7 of benzopyran ring (Figure 1) . Introduction of dimethyl (1a, 1b), spirocyclopentyl (2a, 2b) , spirocyclohexyl (3a, 3b) or phenyl group (4a, 4b) at C-2 Figure 2A , which demonstrated that these compounds were cytotoxic rather than cytostatic.
Tumor specificity. TS vales were calculated by dividing the mean CC 50 value for three types of normal cells by that for four OSCC cell lines (D/B, Table I ). Compounds 1a, 1b, 2a, 2b, 3a, 3b, 4a and 4b showed very low tumor specificity (TS=1.0-1.3). On the other hand, compounds 5a, 5b, 6a and 6b showed much higher tumor specificity (TS=3.6-7.0). In particular, compound 5b (TS=7.0) showed comparable tumor specificity with melphalan (TS=10.9) ( Table I ). Considering that HGF is the normal cell type corresponding to cancer cell Ca9-22 (both derived from gingival tissues), TS values were also generated by dividing the average CC 50 value for HGF cells by that for Ca9-22 cells (C/A, Table I ). Compounds 5a, 5b, 6a and 6b (TS=7.2-13.5) showed slightly higher tumor specificity than melphalan (TS=5.7). Compound 5b had the highest TS value (13.5) ( Table I) .
PSE value.
In order to identify the most promising compounds in terms of both good potency and selective cytotoxicity, PSE values were calculated. Compounds 5a, 5b, 6a and 6b had much higher PSE values than compounds 1a, 1b, 2a, 2b, 3a, 3b, 4a and 4b, while that for 5b gave comparable PSE value with melphalan (Table I) .
Compounds 5b and 6b at the cytotoxic concentration (30 and 60 μM) produced spread, round cells, but failed to produce a population of shrunken cells, in contrast to actinomycin D-treated apoptotic cells ( Figure 2B ). Western blot analysis failed to detect cleaved products of poly (ADPribose) polymerase (PARP) and caspase-3, in contrast to actinomycin D (data not shown).
Computational analysis. We next performed the QSAR analysis of the 12 furo[2,3-b]chromones in regards to their cytotoxicity against tumor cells and normal cells. Among a total of 288 MOE descriptors, seven descriptors correlated well with cytotoxicity and tumor specificity (Table III) .
Cytotoxicity of the 12 furo[2,3-b]chromones against human OSCC cell lines was correlated positively with double bond (b_double; r 2 =0.989, p<0.0001), size and lipophilicity (SlogP_VSA2; r 2 =0.989, p<0.0001) and bond stretch (E_str; r 2 =0.633, p=0.002), while negatively with synthetic feasibility (r synth; r 2 =0.930, p<0.0001), shape (std_dim3; r 2 =0.866, p<0.0001) and density (dens; r 2 =0.622, p=0.0023) (Figure 3) .
Cytotoxicity 
Discussion
The present study demonstrated that among 12 furo [2,3-b] chromones, compounds introduced with dimethyl (1a, 1b), spirocyclopentyl (2a, 2b), spirocyclohexyl (3a, 3b) or phenyl group (4a, 4b) at C-2 position showed essentially no cytotoxic activity nor tumor specificity, whereas compounds with phenylethenyl (5a, 5b) or propenyl (6a, 6b) group significantly enhanced the cytotoxicity and tumor specificity. Among the latter group, (5b) showed the greatest tumor specificity (evaluated by TS and PSE value), comparable with that of melphalan, although much weaker than that of 5-fluorouracil (5-FU) and doxorubicin (Table I ). We also found that when a methoxy group was introduced at C-7 of benzopyran ring, both TS and PSE values of most of the compounds increased, especially of (5b) ( Table IV) . It was unexpected that both (5b) and (6b) at cytotoxic concentration would not induce apoptotic cells characterized by cell shrinkage.
It is difficult to demonstrate that these compounds actually lack the ability to induce apoptosis. In order to elucidate the mechanism of cell death induction by these compounds, the possibility of the induction of other types of cells and growth arrest in OSCC cells should be tested. QSAR analysis demonstrated that tumor selectivity of furo [2,3-b] chromone derivatives strongly correlated with intramolecular unsaturated bond number, molecular flexibility, molecular density, lipophilicity, molecular size, and molecular shape. Chemical modification of the lead compound may be a potential choice for designing a new type of anticancer drug.
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